---
subtitle: No homepage, yet.
date: 2018-08-22 12:24:50
layout: layouts/full.njk
templateEngineOverride: njk
---
<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Industry partnerships | European Bioinformatics Institute</title>
  <meta name="description" content="EMBL-EBI" /><!-- Describe what this page is about -->
  <meta name="keywords" content="bioinformatics, europe, institute" /><!-- A few keywords that relate to the content of THIS PAGE (not the whol project) -->
  <meta name="author" content="EMBL-EBI" /><!-- Your [project-name] here -->
  <meta name="HandheldFriendly" content="true" />
  <meta name="MobileOptimized" content="width" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <meta name="theme-color" content="#70BDBD" /> <!-- Android Chrome mobile browser tab color -->

  <!-- Add information on the life cycle of this page -->
  <meta name="ebi:owner" content="External Relations" /> <!-- Who should be contacted about changes -->
  <meta name="ebi:review-cycle" content="90" /> <!-- In days, how often should the content be reviewed -->
  <meta name="ebi:last-review" content="2018-04-09" /> <!-- The last time the content was reviewed -->

  <!-- If you link to any other sites frequently, consider optimising performance with a DNS prefetch -->
  <link rel="dns-prefetch" href="//www.ebi.ac.uk" />

  <!-- If you have custom icon, replace these as appropriate.
       You can generate them at realfavicongenerator.net -->
  <link rel="icon" type="image/x-icon" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/favicon-32x32.png" />
  <link rel="icon" type="image/png" sizes="192×192" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/android-chrome-192x192.png" /> <!-- Android (192px) -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/apple-icon-114x114.png" /> <!-- For iPhone 4 Retina display (114px) -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/apple-icon-72x72.png" /> <!-- For iPad (72px) -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/apple-icon-144x144.png" /> <!-- For iPad retinat (144px) -->
  <link rel="apple-touch-icon-precomposed" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/apple-icon-57x57.png" /> <!-- For iPhone (57px) -->
  <link rel="mask-icon" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/safari-pinned-tab.svg" color="#ffffff" /> <!-- Safari icon for pinned tab -->
  <meta name="msapplication-TileColor" content="#2b5797" /> <!-- MS Icons -->
  <meta name="msapplication-TileImage" content="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/images/logos/EMBL-EBI/favicons/mstile-144x144.png" />

  <!-- CSS: implied media=all -->
  <!-- CSS concatenated and minified via ant build script-->
  <link rel="stylesheet" href="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/css/ebi-global.css" type="text/css" media="all" />
  <link rel="stylesheet" href="https://ebi.emblstatic.net/web_guidelines/EBI-Icon-fonts/v1.3/fonts.css" type="text/css" media="all" />

  <!-- Use this CSS file for any custom styling -->
  <!--
    <link rel="stylesheet" href="css/custom.css" type="text/css" media="all" />
  -->

  <meta name="ebi:masthead-color" content="#000000" />
  <meta name="ebi:masthead-image" content="https://www.ebi.ac.uk/web_guidelines/EBI-Framework/v1.1/images/backgrounds/industry-blue-4.jpg" />  <meta name="twitter:card" content="summary" />
  <meta name="twitter:site" content="@emblebi" />
  <meta name="twitter:site:id" content="123582098" />
  <meta name="twitter:creator" content="@emblebi" />
  <meta name="twitter:creator:id" content="123582098" />
  <meta name="twitter:title" content="Contact us" />
  <meta name="twitter:url" content="http://www.ebi.ac.uk/about/contact" />
  <meta name="twitter:description" content="Contact details for EMBL-EBI" />


  <!-- you can replace this with theme-[projectname].css. See http://www.ebi.ac.uk/web/style/colour for details of how to do this -->
  <!-- also inform ES so we can host your colour palette file -->
  <link rel="stylesheet" href="//ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/css/theme-ebi-industry.css" />
  <!-- end CSS-->
</head>

<body class="ebi-vf1-integration"><!-- add any of your classes or IDs -->
  <div id="skip-to">
    <ul>
      <li><a href="#content">Skip to main content</a></li>
      <li><a href="#local-nav">Skip to local navigation</a></li>
      <li><a href="#global-nav">Skip to EBI global navigation menu</a></li>
      <li><a href="#global-nav-expanded">Skip to expanded EBI global navigation menu (includes all sub-sections)</a></li>
    </ul>
  </div>

  <header id="masthead-black-bar" class="clearfix masthead-black-bar">
    <nav class="row">
      <ul id="global-nav" class="menu">
        <!-- set active class as appropriate -->
        <li class="home-mobile"><a href="//www.ebi.ac.uk"></a></li>
        <li class="home"><a href="//www.ebi.ac.uk">EMBL-EBI</a></li>
        <li class="services"><a href="//www.ebi.ac.uk/services">Services</a></li>
        <li class="research"><a href="//www.ebi.ac.uk/research">Research</a></li>
        <li class="training"><a href="//www.ebi.ac.uk/training">Training</a></li>
        <li class="about active"><a href="//www.ebi.ac.uk/about">About us</a></li>
        <li class="search">
          <a href="#" data-toggle="search-global-dropdown"><span class="show-for-small-only">Search</span></a>
          <div id="search-global-dropdown" class="dropdown-pane" data-dropdown data-options="closeOnClick:true;">
          <!-- The dropdown menu will be programatically added by script.js -->
          </div>
        </li>
        <li class="float-right show-for-medium embl-selector">
          <button class="button float-right" type="button" data-toggle="embl-dropdown">Hinxton</button>
          <!-- The dropdown menu will be programatically added by script.js -->
        </li>
      </ul>
    </nav>
  </header>
  <div data-sticky-container>
    <header id="masthead" class="masthead" data-sticky data-sticky-on="large" data-top-anchor="content:top" data-btm-anchor="content:bottom">
      <div class="masthead-inner row">
        <!-- local-title -->
        <div class="columns medium-12" id="local-title">
          <h1><a href="/industry" title="Back to Industry">Industry</a></h1>
        </div>
        <!-- /local-title -->
        <!-- local-nav -->
        <nav>
          <ul id="local-nav" class="dropdown menu float-left" data-description="navigational">
            <li class="menu-3038 active-trail first active"><a href="/industry" class="active-trail active">Overview</a></li>
            <li class="menu-3133"><a href="/industry/private" title="Industry Programme member login">Members area</a></li>
            <li class="menu-3131"><a href="/industry/workshops" title="Industry programme workshops">Workshops</a></li>
            <li class="menu-3130"><a href="/industry/sme-forum" title="EMBL-EBI: supporting small and medium-sized enterprise">SMEs</a></li>
            <li class="menu-3132 last"><a href="/industry/contact" title="Contact the Industry Programme">Contact us</a></li>
          </ul>
        </nav>
        <!-- /local-nav -->
      </div>
    </header>
  </div>
  <div id="content">
    <!-- Suggested layout containers -->
    <section id="main-content-area" class="" role="main">
      <!-- Your menu structure should make a breadcrumb redundant, but if a breadcrump is needed uncomment the below -->
      <!-- <nav aria-label="You are here:" role="navigation">
        <ul class="breadcrumbs">
          <li><a href="../../">EBI Framework</a></li>
          <li><a href="../">Sample pages</a></li>
          <li>
            <span class="show-for-sr">Current: </span> Blank boilerplate
          </li>
        </ul>
      </nav> -->

      <!--.l-main -->
      <main id="main-content-area" role="main" class="row l-main">

        <!-- Beta banner -->
        <!-- <link rel="import" href="https://dev.beta.embl.org/api/v1/pattern.html?filter-content-type=article&filter-id=9102&pattern=node-body&source=contenthub" data-target="self" data-embl-js-content-hub-loader> -->

        <section class="vf-intro | embl-grid embl-grid--has-centered-content">
        <div>
        <!-- empty -->
        </div>
        <div class=" vf-u-margin__top--xxl">
        <div class="vf-intro__heading vf-u-margin__bottom--l vf-u-margin__top--xxl">Industry partnerships</div>
        <p class="vf-lede vf-u-margin__bottom--l">The European Bioinformatics Institute (EMBL-EBI) is a global leader in the interrogation, analysis and dissemination of large biological datasets.</p>
        <p class="vf-intro__text">EMBL-EBI empowers companies of all sizes to realise the potential of big data. We combine our unique data expertise with a company’s R&D knowledge to develop and commercialise innovative technologies and solutions.</p>
        <p class="vf-intro__text">EMBL-EBI is pushing the boundaries of the life sciences. We have a robust track record of innovative collaborations with the private sector, and we welcome opportunities to explore new strategic partnerships and ventures.</p>
        </div>
        </section>

        <!-- Facts and figures -->
        <section class="embl-grid embl-grid--has-centered-content">
        <div>
          <h4 class="vf-text vf-text-heading--3 vf-u-margin__top--">EMBL-EBI <span class="nowrap">at a glance</span></h4>
        </div>
        <div class="">
          <section class="vf-grid vf-grid__col-2">
            <div class="vf-box vf-card--by-the-numbers">
              <div class="vf-card__image vf-u-background-color--blue">
                <i class="icon icon-common icon-analyse"></i>

                <h3 class="vf-card__title">
                  400+
                </h3>
                <p class="vf-card__text">
                  data scientists
                </p>
              </div>
            </div>

            <div class="vf-box vf-card--by-the-numbers">
              <div class="vf-card__image vf-u-background-color--blue">
                <i class="icon icon-conceptual icon-structures-3d"></i>

                <h3 class="vf-card__title">
                  150+
                </h3>
                <p class="vf-card__text">
                  Petabytes of open data accessed 68 million times every day
                </p>
              </div>
            </div>

            <div class="vf-box vf-card--by-the-numbers">
              <div class="vf-card__image vf-u-background-color--blue">
                <i class="icon icon-conceptual icon-literature"></i>

                <h3 class="vf-card__title">
                  300+
                </h3>
                <p class="vf-card__text">
                  scientific publications <span class="nowrap">every year</span>
                </p>
              </div>
            </div>

            <div class="vf-box vf-card--by-the-numbers">
              <div class="vf-card__image vf-u-background-color--blue">
                <i class="icon icon-conceptual icon-cross-domain"></i>

                <h3 class="vf-card__title">
                  25 years
                </h3>
                <p class="vf-card__text">
                  of industry collaboration
                </p>
              </div>
            </div>

          </section>
        </div>
        <div><!-- empty --></div>
        </section>

        <style>
        .vf-box.vf-card--by-the-numbers  {
          background-color: rgb(48, 127, 226);
          overflow: hidden;
          position: relative;
          padding: 0;
        }
        .vf-card--by-the-numbers .vf-card__image .vf-card__text,
        .vf-card--by-the-numbers .vf-card__image .vf-card__title {
          padding-left: 25px;
          color: white;
          position: relative;
          z-index: 3;
        }
        .vf-card--by-the-numbers .vf-card__image .vf-card__title {
          padding-top: 25px;
          font-size: 4em;
          margin-bottom: 0;
        }
        .vf-card--by-the-numbers .vf-card__image .vf-card__text {
          max-width: 250px;
          padding-bottom: 1rem;
        }
        .vf-card--by-the-numbers .vf-card__image .icon {
          color: rgb(139, 184, 232);
          font-size: 11em;
          position: absolute;
          z-index: 1;
          right: -20px;
          bottom: -60px;
          /* transform: rotate(-4deg); */

        }
        .vf-card__image {
          /* this works better when a square-ish image cover needs to be cropped */
          object-position: bottom;

        }
        </style>





        <!-- Facts and figures -->
        <section class="embl-grid embl-grid--has-centered-content hide">
        <div>
          <h4 class="vf-text vf-text-heading--3 vf-u-margin__top--">EMBL-EBI <span class="nowrap">at a glance</span></h4>
          <!-- <span class="vf-text">EMBL-EBI at a glance</span> -->
        </div>
        <div class="vf-content">
          <section class="vf-grid vf-grid__col-4">
            <div>
              <h5 class="vf-text vf-text-heading--2">400+ </h5>
              <span class="vf-text">data scientists</span>
            </div>

            <div>
              <h5 class="vf-text vf-text-heading--2">150+</h5>
              <span class="vf-text">Petabytes of open data accessed 68 million times every day</span>
            </div>

            <div>
              <h5 class="vf-text vf-text-heading--2">300+</h5>
              <span class="vf-text">scientific publications every year</span>
            </div>

            <div>
              <h5 class="vf-text vf-text-heading--2">25 years</h5>
              <span class="vf-text">of industry collaboration</span>
            </div>


          </section>
        </div>
        <div><!-- empty --></div>
        </section>


        <section class="embl-grid embl-grid--has-centered-content vf-u-padding__top--xl vf-u-padding__bottom--xl">
          <div>
            <h4 class="vf-text vf-text-heading--3">How EMBL-EBI can help</h4>
          </div>
          <div class="vf-content">
            <p>Could use some text here, a la: Here are some examples of how EMBL-EBI has partnered with other peeps to do great stuff and some more words that go like this.</p>
            <ul>
              <li><a href="#" class="vf-link">Establish disruptive decision-making systems</a> (#link_to_OT_case_study_in_a_seperate_page)</li>
              <li><a href="#" class="vf-link">Design robust data coordination platforms</a> (#link_to_HCA_case_study_once_ready)</li>
              <li><a href="#" class="vf-link">Enable data-driven discoveries</a> (#link_to_Biocatalysts_case_study_in_a_seperate_page)</li>
              <li><a href="https://www.ebi.ac.uk/industry/contact" class="vf-link">Join our exclusive Industry Programme</a></li>
            </ul>

            <p>Want to find out more? <a href="https://www.ebi.ac.uk/industry/contact" class="vf-link">Get in touch</a>.</p>

          </div>
          <div>
            <!-- empty -->
          </div>
        </section>

        <style>
          .vf-thumbnail-grid .vf-thumbnail-grid__cell {
              margin: auto;
              margin-right: 20px;
          }
        </style>
        <section class="embl-grid embl-grid--has-centered-content vf-u-padding__top--xl">
          <div>
          <h4 class="vf-text vf-text-heading--3">Collaborating with EMBL-EBI</h4>
          </div>
          <div class="vf-content">
          <!--   <p>EMBL-EBI has already collaborated with more than a bunch of things ... feels like a bit of text is needed here?</p> -->
              <section class="vf-grid vf-grid__col-5 vf-thumbnail-grid">
          <div class="vf-thumbnail-grid__cell">
          <img src="https://www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/industry_office/logos/Biogen_214x65.jpg" alt="Biogen" />
          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="https://www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/industry_office/logos/Celgene-logo.png" alt="Celgene" />
          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="logos/chan-zuckerberg.svg" alt="Chan Zuckerberg Initiative" />
          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="https://www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/industry_office/logos/GSK_214x65.jpg" />
          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="https://www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/industry_office/logos/NovoNordisk_214x65.jpg" alt="NovoNordisk" />

          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="http://www.pmlive.com/__data/assets/image/0006/1256190/oxford-nanopore-technologies_logo.jpg" alt="Oxford Nanopore" />
          </div>
          <div class="vf-thumbnail-grid__cell">

            <img src="//www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/industry_office/logos/SanofiAventis_214x65.jpg" border="0" alt="Sanofi - EMBL-EBI Industry Programme member" width="214" height="65">

          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="https://www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/industry_office/logos/Syngenta_214x65.jpg" />
          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="https://www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/external_relations/images/Takeda_EMBL-EBI_Industry_Programme.png" alt="Takeda" />
          </div>
          <div class="vf-thumbnail-grid__cell">
          <img src="https://www.ebi.ac.uk/sites/ebi.ac.uk/files/groups/industry_office/logos/Unilever_214x65.jpg" alt="Unilever" />
          </div>
            </section>

          </div>
          <div><!-- empty --></div>
        </section>

        <hr class="vf-divider"/>

        <section class="embl-grid embl-grid--has-centered-content vf-u-padding__top--xxl vf-u-margin__top--xxl">
        <div>
          <h4 class="vf-text vf-text-heading--3">Featured <span class="nowrap">case study</span></h4>
        </div>

          <div class="">
            <section class="">
                  <div class="vf-content">

                    <img class="float-right" style="max-width: 150px" src="data:image/jpeg;base64,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" />

                    <div class="vf-intro__heading vf-u-margin__bottom--l vf-u-margin__top--s">Open Targets</div>

                    <p class="vf-lede vf-u-margin__bottom--xxl">A groundbreaking public-private partnership.</p>
                    <p class="vf-intro__text">Open Targets is a unique, large-scale, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.</p>

                    <h3>The challenge</h3>

                    <p>Only five in 5000 drugs that enter preclinical testing progress to the human testing phase, and only one in 5000 makes it to the market. On average, the process takes twelve years and billions of dollars.</p>

                    <p>One of the biggest barriers in drug discovery today is selecting the right drug target at the beginning of the pipeline the first place.</p>

                    <style>
                    .vf-button--primary:hover {
                       color: #fff;
                    }
                    .accordion-thin-style {
                      background: none;
                    }
                    .accordion-thin-style .accordion-item.is-active > :first-child {
                      display: none;
                    }
                    .accordion-thin-style .accordion-item:first-child > :first-child {
                      border-radius: 4px;
                    }
                    .accordion-thin-style .accordion-content {
                      padding: 0;
                      border: none;
                      background: none;
                      color: unset;

                    }
                    </style>

                    <div class="accordion accordion-thin-style" data-accordion data-allow-all-closed="true">
                      <li class="accordion-item " data-accordion-item>
                        <a class="vf-button vf-button--primary ">Read more</a>
                        <div class="accordion-content" data-tab-content>
                          <h3>The solution</h3>

                          <p>To overcome this challenge, experts from academia and the pharmaceutical  sector came together to create Open Targets. The partnership brings together expertise, skills, evidence and technologies from seven complementary institutions. The aim? Transform drug discovery by systematically identifying and prioritising targets from which safe and effective medicines can be developed.</p>

                          <h3>Open Targets is a partnership</h3>

                          <div><img src="https://d33wubrfki0l68.cloudfront.net/5e24b7acbb41ef76868568a0f3e74d08832c02d4/ffe38/assets/images/opentargets7partners.png" /></div>

                          <p>The current scientific focus of Open Targets includes oncology, immunology and neurodegeneration, but the R&D framework developed can be applied to all aspects of human disease.</p>

                          <h3>The outcomes</h3>

                          <p>Open Targets openly shares its data, software and results with the scientific community. Since its launch, it has released two essential decision-making systems  for drug target identification:</p>

                          <ul>
                            <li>Open Targets Platform - find and prioritise new targets for drug discovery</li>
                            <li>Open Targets Genetics - explore variant-gene-trait associations from UK Biobank and GWAS Catalog</li>
                          </ul>

                          <p>If we ever hope to understand disease mechanisms and improve the existing one in 5000 success rate for drugs making it to the market, pre-competitive collaborations such as Open Targets, which bridge the gap between academia and industry, are essential.</p>

                          <p>There is still substantial scope for similar collaborations to help us tackle grand challenges, including other phases of the drug discovery pipeline, crop production, antimicrobial resistance and so much more.</p>

                          <p>EMBL-EBI welcomes new opportunities for such ventures, so if you want to find out more about Open Targets or get involved in setting up a new partnership, <a href="https://www.ebi.ac.uk/industry/contact" class="vf-link">get in touch</a>.</p>

                        </div>
                      </li>
                    </div>

                  </div>
                  <div><!-- empty --></div>
            </div>
          </section>



        <section class="embl-grid embl-grid--has-centered-content vf-u-padding__top--xl hide">
        <div>
          <h4 class="vf-text vf-text-heading--3">Featured <span class="nowrap">case study</span></h4>
        </div>

          <div class="vf-box vf-u-background-color-ui--grey--light">
            <section class="vf-inlay vf-u-background-color-ui--off-white vf-u-text-color--ui--black">
              <section class="vf-inlay__content">
                <main class="vf-inlay__content--full-width">
                  <div class="vf-content">


                    <img class="float-right" style="max-width: 150px" src="data:image/jpeg;base64,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" />

                    <!-- <span class="vf-badge vf-badge--primary">CASE STUDY</span> -->

                    <div class="vf-intro__heading">Open Targets</div>

                    <h3>A groundbreaking public-private partnership</h3>

                    <p>Open Targets is a unique, large-scale, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.</p>

                    <h3>The challenge</h3>

                    <p>Only five in 5000 drugs that enter preclinical testing progress to the human testing phase, and only one in 5000 makes it to the market. On average, the process takes twelve years and billions of dollars.</p>

                    <p>One of the biggest barriers in drug discovery today is selecting the right drug target at the beginning of the pipeline the first place.</p>

                    <style>
                    .vf-button--primary:hover {
                       color: #fff;
                    }
                    .accordion-thin-style {
                      background: none;
                    }
                    .accordion-thin-style .accordion-item.is-active > :first-child {
                      display: none;
                    }
                    .accordion-thin-style .accordion-item:first-child > :first-child {
                      border-radius: 4px;
                    }
                    .accordion-thin-style .accordion-content {
                      padding: 0;
                      border: none;
                      background: none;
                      color: unset;

                    }
                    </style>

                    <div class="accordion accordion-thin-style" data-accordion data-allow-all-closed="true">
                      <li class="accordion-item " data-accordion-item>
                        <a class="vf-button vf-button--primary ">Read more</a>
                        <div class="accordion-content" data-tab-content>
                          <h3>The solution</h3>

                          <p>To overcome this challenge, experts from academia and the pharmaceutical  sector came together to create Open Targets. The partnership brings together expertise, skills, evidence and technologies from seven complementary institutions. The aim? Transform drug discovery by systematically identifying and prioritising targets from which safe and effective medicines can be developed.</p>

                          <h3>Open Targets is a partnership</h3>

                          <div><img src="https://d33wubrfki0l68.cloudfront.net/5e24b7acbb41ef76868568a0f3e74d08832c02d4/ffe38/assets/images/opentargets7partners.png" /></div>

                          <p>The current scientific focus of Open Targets includes oncology, immunology and neurodegeneration, but the R&D framework developed can be applied to all aspects of human disease.</p>

                          <h3>The outcomes</h3>

                          <p>Open Targets openly shares its data, software and results with the scientific community. Since its launch, it has released two essential decision-making systems  for drug target identification:</p>

                          <ul>
                            <li>Open Targets Platform - find and prioritise new targets for drug discovery</li>
                            <li>Open Targets Genetics - explore variant-gene-trait associations from UK Biobank and GWAS Catalog</li>
                          </ul>

                          <p>If we ever hope to understand disease mechanisms and improve the existing one in 5000 success rate for drugs making it to the market, pre-competitive collaborations such as Open Targets, which bridge the gap between academia and industry, are essential.</p>

                          <p>There is still substantial scope for similar collaborations to help us tackle grand challenges, including other phases of the drug discovery pipeline, crop production, antimicrobial resistance and so much more.</p>

                          <p>EMBL-EBI welcomes new opportunities for such ventures, so if you want to find out more about Open Targets or get involved in setting up a new partnership, <a href="https://www.ebi.ac.uk/industry/contact" class="vf-link">get in touch</a>.</p>

                        </div>
                      </li>
                    </div>

                  </div>
                  <div><!-- empty --></div>
                </main>
              </section>
            </div>
          </section>


          <hr class="vf-divider"/>

          <section class="vf-summary-container | embl-grid">

              <div class="vf-section-header">
                <h4 class="vf-text vf-text-heading--3">More about EMBL-EBI</h4>
              </div>

              <div class="vf-section-content | vf-grid vf-grid__col-3">

                <article class="vf-summary">
                  <h3 class="vf-summary__title">
                    <a href="#" class="vf-summary__link">EMBL-EBI's Impact</a>
                  </h3>
                  <p class="vf-summary__text">We collaborate with scientists and engineers all over the world, and provide the infrastructure needed to share data openly in the life sciences.</p>
                </article>

              </div>

          </section>




      </div>


      <!-- END VF 2.0 -->

      </main>
      <!--/.l-main -->

      <!--.l-footer -->
      <footer>
      <div id="global-footer" class="global-footer">
      <nav id="global-nav-expanded" class="global-nav-expanded row">
      <!-- Footer will be automatically inserted by footer.js -->
      </nav>
      <section id="ebi-footer-meta" class="ebi-footer-meta row">
      <!-- Footer meta will be automatically inserted by footer.js -->
      </section>
      </div>

    </section>
    <!-- Optional local footer (insert citation / project-specific copyright / etc here -->
    <!--
    <footer id="local-footer" class="local-footer" role="local-footer">
      <div class="row">
        <span class="reference">How to reference this page: ...</span>
      </div>
    </footer>
    -->
    <!-- End optional local footer -->
  </div>
  <!-- End suggested layout containers / #content -->

  <footer>
    <div id="global-footer" class="global-footer">
      <nav id="global-nav-expanded" class="global-nav-expanded row">
        <!-- Footer will be automatically inserted by footer.js -->
      </nav>
      <section id="ebi-footer-meta" class="ebi-footer-meta row">
        <!-- Footer meta will be automatically inserted by footer.js -->
      </section>
    </div>
  </footer>

  <!-- VF 2.0 CSS, JS -->
  <link rel="stylesheet" href="https://assets.emblstatic.net/vf/v2.4.11/css/styles.css" />
  <script src="https://assets.emblstatic.net/vf/v2.4.11/scripts/scripts.js"></script>

  <!-- JavaScript -->
  <!-- Grab Google CDN's jQuery, with a protocol relative URL; fall back to local if offline -->
  <!--
  <script>window.jQuery || document.write('<script src="../js/libs/jquery-1.10.2.min.js"><\/script>')</script>
  -->
  <script src="//ajax.googleapis.com/ajax/libs/jquery/1.10.2/jquery.min.js"></script>

  <script defer="defer" src="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/js/script.js"></script>

  <!-- The Foundation theme JavaScript -->
  <script src="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/libraries/foundation-6/js/foundation.js"></script>
  <script src="https://ebi.emblstatic.net/web_guidelines/EBI-Framework/v1.3/js/foundationExtendEBI.js"></script>
  <script type="text/JavaScript">$(document).foundation();</script>
  <script type="text/JavaScript">$(document).foundationExtendEBI();</script>

  <!-- Google Analytics details... -->
  <script type="text/javascript">!function(e,a,n,t,i,o,c){e.GoogleAnalyticsObject=i,e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date,o=a.createElement(n),c=a.getElementsByTagName(n)[0],o.async=1,o.src="//www.google-analytics.com/analytics.js",c.parentNode.insertBefore(o,c)}(window,document,"script",0,"ga"),ga("create","UA-629242-1",{cookieDomain:"auto"}),ga("require","linkid","linkid.js"),ga("set","anonymizeIp",!0),ga("send","pageview");</script>
</body>
</html>
